Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Ophthalmology|July 19, 2019
Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech RepublicJan Nemcansky, Alexandr Stepanov, Michal Koubek, et al.
European Journal of Ophthalmology|October 18, 2022
Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech RepublicAlexandr Stepanov, Jan Studnicka, Miroslav Veith, et al.
Cornea|November 6, 2020
Long-term Results of a Combined Procedure of Cataract Surgery and Descemet Membrane Endothelial Keratoplasty With Stromal RimPavel Studeny, Katerina Hlozankova, Deli Krizova, et al.
European Journal of Ophthalmology|November 17, 2020
Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech RepublicAlexandr Stepanov, Jan Nemcansky, Miroslav Veith, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 15, 2025
Efficacy and Safety of Switching from Ranibizumab to Brolucizumab in Age-Related Macular Degeneration: Multicenter Real-World OutcomesLibor Hejsek, Michal Hrevuš, Maria Burova, et al.
Diabetes Research and Clinical Practice|May 31, 2024
Serum autoantibodies against hexokinase 1 manifest secondary to diabetic macular edema onsetDaniela Šimčíková, Jana Ivančinová, Miroslav Veith, et al.
ACS Omega|February 2, 2026
Emulsification Complexity of Silicone Oil in Retinal Surgery: In Vitro Insights into Phase BehaviorBarbora Kamenická, Věra Pěnkavová, Eliška Lyko Vachková, et al.
Value in Health Regional Issues|January 12, 2019
The Burden of Macular Diseases in Central and Eastern Europe-Implications for Healthcare SystemsPolona Jaki Mekjavić, Vilma Jūratė Balčiūnienė, Lala Ćeklić, et al.
JAMA Ophthalmology|November 19, 2020
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical TrialSe Joon Woo, Miroslav Veith, Jan Hamouz, et al.
JAMA Ophthalmology|June 8, 2023
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical TrialSe Joon Woo, Mario Bradvica, Attila Vajas, et al.
Pageof 3